½ÃÀ庸°í¼­
»óǰÄÚµå
1355625

¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°, ±â¼úº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Cardiovascular Surgical Devices Market Size study & Forecast, by Type, by Technology and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÇ÷°ü ¼ö¼ú±â±¸´Â ½ÉÀå°ú Ç÷°üÀ» Æ÷ÇÔÇÑ ½ÉÇ÷°ü°è ¼ö¼ú¿¡ »ç¿ëµÇ´Â ÀÇ·á±â±¸ ¹× ÅøÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ Àåºñ´Â ¿Ü°ú Àǻ簡 ´Ù¾çÇÑ ½ÉÇ÷°ü°è ÁúȯÀ» Áø´ÜÇϰí Ä¡·áÇÏ´Â µ¥ µµ¿òÀ» ÁÖ±â À§ÇØ °í¾ÈµÈ °ÍÀÔ´Ï´Ù. ½ÉÇ÷°ü ¼ö¼ú ±â±¸ ½ÃÀåÀº °í·ÉÃþ¿¡¼­ Ç÷°ü Áúȯ°ú ¼±Ãµ¼º ±âÇü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼¼°è¿¡¼­ Àα¸ °í·ÉÈ­, ¿µ¾ç½ÇÁ¶, ºñ¸¸À² Áõ°¡·Î ÀÎÇØ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ ¸ðµç °ÍÀÌ ½ÉÇ÷°ü ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¸¸¼º ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í È¿À²ÀûÀÎ ÀåºñÀÇ °¡¿ë¼º Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ¼ö¼ú ±â¹ýÀÇ ¹ßÀü, °í·ÉÈ­, ÀÇ·áºñ ÁöÃâ Áõ°¡, ÀÎ½Ä Áõ°¡´Â Àü¹ÝÀûÀ¸·Î ½ÉÇ÷°ü ¼ö¼ú Àåºñ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ãÀÌ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â ¼¼°è¿¡¼­ ¸Å³â ¾à 1,730¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ 2030³â¿¡´Â ¾à 2,360¸¸ ¸íÀÌ »ç¸ÁÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¶ÇÇÑ ÀåºñÀÇ ±â¼ú ¹ßÀü°ú ½ÉÇ÷°ü ¼ö¼ú Àåºñ¿Í °ü·ÃµÈ ¿¬±¸ ¹× °³¹ß Ȱµ¿ Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ±ÔÁ¦ ´ç±¹ÀÇ ¾ö°ÝÇÏ°í ±ä ½ÂÀÎ ÀýÂ÷´Â 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ½ÉÀåÇ÷°ü ¼ö¼ú ±â±â ½ÃÀå Á¶»ç¿¡¼­ °í·ÁÇÑ ÁÖ¿ä Áö¿ª : ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, ¹Ì±¹°ú ij³ª´ÙÀÇ ½ÉÀ庴 À¯º´·ü Áõ°¡, ÀÌ Áö¿ªÀÇ ±â¼ú ¹ßÀü Áõ°¡, Á¦Ç° Çõ½Å ¹× °³Ã´ÀÇ ¼ºÀåÀ¸·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡, ¸¸¼º ½ÉÀ庴 À¯º´·ü Áõ°¡, ÀÇ·á ºÐ¾ß¿¡ ´ëÇÑ °ø°ø ¹× ¹Î°£ ÅõÀÚ Áõ°¡, Á¤ºÎÀÇ ´ÜÇÕµÈ ³ë·Â µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°èÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³â
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå ¿ªÇÐ

  • ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ¸¸¼º ½ÉÁúȯÀÇ À¯º´·ü Áõ°¡
      • °í·ÉÈ­ Àα¸ÀÇ Áõ°¡
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
      • ±ÔÁ¦±â°ü¿¡ ÀÇÇÑ ¾î·Æ°í ±ä ½ÂÀÎ ÇÁ·Î¼¼½º
    • ½ÃÀå ±âȸ
      • ±â±âÀÇ ±â¼úÀû Áøº¸
      • ¿¬±¸°³¹ßÀÇ È°¹ßÈ­

Á¦4Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð¡¤Á¦¾È

Á¦5Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå : À¯Çüº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå : À¯Çüº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå À¯Çüº° ÃßÁ¤¡¤¿¹Ãø : 2020-2030³â
  • ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ÁßÀçÀû ½ÉÀå¿Ü°ú
    • ½ÉÀå ¸®µë °ü¸®
    • ±âÁ¸ ½ÉÀå ¼ö¼ú
    • ±âŸ

Á¦6Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå : ±â¼úº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå : ±â¼úº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå : ±â¼úº° ÃßÁ¤¡¤¿¹Ãø 2020-2030³â
  • ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • °ü·ù¿ë ÀÏȸ¿ë
    • Àΰø½ÉÆó±â
    • ½ÉÀå ¼ö¼ú Ä¡·á
    • ½É½Çº¸Á¶±â±â
    • ½ÉÀå ÀýÁ¦ ±â±â
    • ±âŸ

Á¦7Àå ¼¼°èÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå, Áö¿ª ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå, Áö¿ªº° ½ÃÀå ½º³À¼ô
  • ºÏ¹Ì
    • ¹Ì±¹
      • À¯Çü ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ±â¼úº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå ½º³À¼ô
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå ½º³À¼ô
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÉÀåÇ÷°ü ¿Ü°ú¿ë µð¹ÙÀ̽º ½ÃÀå ½º³À¼ô
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Medtronic Inc
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ °¡¿ë¼º¿¡ µû¸§)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Maquet GmbH & Co. KG
    • Sorin Group
    • Terumo Corp
    • C.R. Bard Inc
    • SEMMT Inc
    • St. Jude Medical
    • Medwaves Incorporated
    • Edward Lifesciences
    • EndoPhotonix Inc.

Á¦9Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç ÀüÁ¦Á¶°Ç
KSA 23.10.17

Cardiovascular surgical devices are medical instruments and tools used in surgical procedures involving the cardiovascular system, which includes the heart and blood vessels. These devices are designed to assist surgeons in diagnosing and treating various cardiovascular conditions and diseases. The market for cardiovascular surgical devices is anticipated to be driven by the increase in vascular problems and congenital anomalies among the elderly population. Globally, the prevalence of cardiovascular disorders is increasing as a result of ageing populations, poor nutrition, and rising obesity rates, all of which are predicted to boost the demand for cardiovascular procedures. Also, growing prevalence of chronic heart diseases and increasing availability of efficient devices are anticipated to support the market growth during the forecast period.

Moreover, the growing prevalence of cardiovascular disorders, along with advancements in surgical techniques, an aging population, rising healthcare expenditure, and increased awareness, collectively contribute to the growth of the Cardiovascular Surgical Devices Market. The demand for these devices is expected to continue to rise as the burden of cardiovascular diseases persists. According to the American Heart Association, cardiovascular diseases are projected around 17.3 million deaths globally every year. And the cases are estimated to rise about 23.6 million by 2030.

Additionally, rising technological advancement in devices and growing research and development activities related to cardiovascular surgical devices are anticipated to create lucrative opportunities for the market during forecast period. However, the stringent and longer approval processes by the regulatory authorities stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cardiovascular Surgical Devices Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, growing prevalence of heart diseases in the U.S. and Canada, rising technological advancement and growing product innovation and development in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing prevalence of chronic heart diseases, rising public-private investments in healthcare sector, and cohesive government initiatives are anticipated to support the market growth during forecast period.

Major market players included in this report are:

  • Medtronic Inc
  • Maquet GmbH & Co. KG
  • Sorin Group
  • Terumo Corp
  • C.R. Bard Inc
  • SEMMT Inc
  • St. Jude Medical
  • Medwaves Incorporated
  • Edward Lifesciences
  • EndoPhotonix Inc.

Recent Developments in the Market:

  • In July 2021, Angel Medical Systems, Inc. started the first commercial implantation of their flagship product, "The Guardian" device in the U.S. region.

Global Cardiovascular Surgical Devices Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Technology, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Interventional Cardiac Surgery
  • Cardiac Rhythm Management
  • Traditional Cardiac Surgery
  • Others

By Technology:

  • Perfusion Disposables
  • Cardiopulmonary Bypass Equipment
  • Beating Heart Surgery Treatment
  • Ventricular Assist Device
  • Cardiac Ablation Devices
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Cardiovascular Surgical Devices Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Cardiovascular Surgical Devices Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Cardiovascular Surgical Devices Market, by Technology, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cardiovascular Surgical Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cardiovascular Surgical Devices Market Dynamics

  • 3.1. Cardiovascular Surgical Devices Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of chronic heart diseases
      • 3.1.1.2. Rising ageing populations
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent and longer approval processes by the regulatory authorities
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancement in devices
      • 3.1.3.2. Growing research and development activities

Chapter 4. Global Cardiovascular Surgical Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiovascular Surgical Devices Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Cardiovascular Surgical Devices Market by Type, Performance - Potential Analysis
  • 5.3. Global Cardiovascular Surgical Devices Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Cardiovascular Surgical Devices Market, Sub Segment Analysis
    • 5.4.1. Interventional Cardiac Surgery
    • 5.4.2. Cardiac Rhythm Management
    • 5.4.3. Traditional Cardiac Surgery
    • 5.4.4. Others

Chapter 6. Global Cardiovascular Surgical Devices Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Cardiovascular Surgical Devices Market by Technology, Performance - Potential Analysis
  • 6.3. Global Cardiovascular Surgical Devices Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
  • 6.4. Cardiovascular Surgical Devices Market, Sub Segment Analysis
    • 6.4.1. Perfusion Disposables
    • 6.4.2. Cardiopulmonary Bypass Equipment
    • 6.4.3. Beating Heart Surgery Treatment
    • 6.4.4. Ventricular Assist Device
    • 6.4.5. Cardiac Ablation Devices
    • 6.4.6. Others

Chapter 7. Global Cardiovascular Surgical Devices Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Cardiovascular Surgical Devices Market, Regional Market Snapshot
  • 7.4. North America Cardiovascular Surgical Devices Market
    • 7.4.1. U.S. Cardiovascular Surgical Devices Market
      • 7.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Technology breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Cardiovascular Surgical Devices Market
  • 7.5. Europe Cardiovascular Surgical Devices Market Snapshot
    • 7.5.1. U.K. Cardiovascular Surgical Devices Market
    • 7.5.2. Germany Cardiovascular Surgical Devices Market
    • 7.5.3. France Cardiovascular Surgical Devices Market
    • 7.5.4. Spain Cardiovascular Surgical Devices Market
    • 7.5.5. Italy Cardiovascular Surgical Devices Market
    • 7.5.6. Rest of Europe Cardiovascular Surgical Devices Market
  • 7.6. Asia-Pacific Cardiovascular Surgical Devices Market Snapshot
    • 7.6.1. China Cardiovascular Surgical Devices Market
    • 7.6.2. India Cardiovascular Surgical Devices Market
    • 7.6.3. Japan Cardiovascular Surgical Devices Market
    • 7.6.4. Australia Cardiovascular Surgical Devices Market
    • 7.6.5. South Korea Cardiovascular Surgical Devices Market
    • 7.6.6. Rest of Asia Pacific Cardiovascular Surgical Devices Market
  • 7.7. Latin America Cardiovascular Surgical Devices Market Snapshot
    • 7.7.1. Brazil Cardiovascular Surgical Devices Market
    • 7.7.2. Mexico Cardiovascular Surgical Devices Market
  • 7.8. Middle East & Africa Cardiovascular Surgical Devices Market
    • 7.8.1. Saudi Arabia Cardiovascular Surgical Devices Market
    • 7.8.2. South Africa Cardiovascular Surgical Devices Market
    • 7.8.3. Rest of Middle East & Africa Cardiovascular Surgical Devices Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Medtronic Inc
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Maquet GmbH & Co. KG
    • 8.3.3. Sorin Group
    • 8.3.4. Terumo Corp
    • 8.3.5. C.R. Bard Inc
    • 8.3.6. SEMMT Inc
    • 8.3.7. St. Jude Medical
    • 8.3.8. Medwaves Incorporated
    • 8.3.9. Edward Lifesciences
    • 8.3.10. EndoPhotonix Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦